St. Jude Medical (NYSE:STJ) announced Thursday that it is laying of 300 employees as part of a broader restructuring aimed to lower operating costs. In a news release, the Minnesota medical device maker said that it is centralizing support functions in information technology, human resources, legal, business development and many marketing functions. The job cuts are […]
St. Jude Medical (NYSE:STJ) announced Tuesday that its renal denervation technology was effective in lowering blood pressure of patients whose hypertension remained stubbornly high despite being on many medications. The EnligHTN technology was effective in that, on average, patients saw their systolic blood pressure lowered 28 mmHg points after 30 days of treatment. The effect was […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
UPDATE: Scroll down to see St. Jude Medical’s detailed statement. Dr. Robert Hauser will not make the list of St. Jude Medical’s most favorite cardiologists any time soon. Hauser, a prominent cardiologist from Minneapolis Heart Institute known for studying how heart devices function, has concluded that St. Jude Medical’s (NYSE:STJ) highly touted Durata lead is […]
If you have not already heard, there was more news (see theHeart.org) on the troubled St. Jude Medical Riata family of ICD leads. The high voltage leads were recalled in December of 2011 and estimates are that 79,000 remain implanted. Perhaps more problematic for the company is the structural similarity of its current ICD lead […]
Looks like the Food and Drug Administration is not buying St. Jude Medical’s (NYSE:STJ) insistence that the Durata ICD lead is safe. While some have argued that the Durata leads are very similar in design to the recalled Riata and Riata ST defibrillator leads and will fail too, St. Jude has long fought the notion […]
By now, many of you have heard the news that medical device manufacturer and supplier Vante fired its chief financial officer for berating a Chick-fil-A employee because she worked at a “horrible corporation” with “horrible values.” Adam Smith, a self-declared heterosexual, filmed himself going through a Chick-fil-A drive-thru harassing a female employee for its President […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Behold, convergence. A startup backed by the likes of Medtronic and Novartis has combined sensors with mobile technology, pharmaceuticals and medical devices to develop what’s being hyped as the U.S.’s first smart pill system. Just cleared by the U.S. Food and Drug Administration, Proteus Digital Health‘s tiny ingestible sensor is used with a companion wearable […]
If people are looking for confirmation that the global cardiac rhythm management market has declined as much as it could and will fall no further, they have to wait a while. A week ago St. Jude Medical CEO Dan Starks admitted that the company has been routinely too optimistic in predicting the bottom of the […]
St. Jude Medical (NYSE:STJ) may have performed better than expected in the cardiac rhythm management business in the second quarter, but that doesn’t necessarily mean the company is confident about seeing a rosier picture around the corner. The Minnesota medical device company reported Wednesday that revenue fell 2 percent to $1.41 billion from $1.46 […]
St. Jude Medical’s (NYSE:STJ) Durata leads have held up quite well so far despite the notion that many have that the leads are similar in design to the recalled Riata leads and will therefore fail. The company chalks up Durata’s resilience to lead abrasion to a polymer insulation called Elast-Eon that St. Jude has re-branded […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
St. Jude Medical (NYSE:STJ) CEO Dan Starks told analysts Wednesday that the company estimates it will pay about $60 million as a result of the medical device tax in 2013, and described it as a tax that will have an unintended negative impact on the medical device industry. In a call discussing results of the […]
Given how St. Jude Medical (NYSE:STJ) has promoted the near infallibility of the Durata defibrillator’s lead insulation, it was imperative that executives move fast when a report emerged that cables had poked through their insulation in one patient. That single report had caused the stock to slide 6 percent in a day. On Friday, just […]
St. Jude Medical (NYSE:STJ) announced Monday that the U.S. Food and Drug Administration has cleared a vascular plug for use in procedures that selectively block abnormal blood vessels. St. Jude Medical’s AMPLATZER Vascular Plug 4 can be used with a standard catheter in lieu of an embolization coil. As such, it is a first of […]
St. Jude Medical (NYSE:STJ) is having a bad week. An unconfirmed report about lead wires poking through their insulation on its newer, apparently more resistant ICD lead saw the stock slide 6 percent on Tuesday. An analyst called it a overreaction, though there is cold comfort in that. And now, the Minnesota medical device company […]
Two events this week prompted investors to disproportionately reward and punish stocks of two medical technology companies: Edwards Lifesciences (NYSE:EW) and St. Jude Medical (NYSE:STJ). One piece of news was largely expected — a panel at the U.S. Food and Drug Administration gave a thumbs up to the expanded indication for Edwards Lifesciences’ SAPIEN transcatheter […]